TWD
CRMD icon

True Wealth Design’s CorMedix CRMD Stock Holding History

True Wealth Design’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-5
Closed -$40 – 2633
2026
Q2 		$40 Buy
+5
New +$40 ﹤0.01% 2608

Other funds holding CRMD

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

True Wealth Design's CRMD Position: Q3 2026 in Review

True Wealth Design sold out of CorMedix (CRMD) in Q3 2026, closing a stake of 5 shares — an estimated $40 sold.

True Wealth Design first reported a position in CRMD in Q2 2026 and held it in 1 quarter. The position peaked at $40 in Q2 2026. 6 funds tracked by Wall St. Rank hold CRMD as of Q3 2026.

  • True Wealth Design reported no remaining CorMedix position as of Q3 2026 after selling out during the quarter.
  • True Wealth Design sold 5 CorMedix shares in Q3 2026, an estimated $40.
  • True Wealth Design first reported a position in CorMedix in Q2 2026 and held it in 1 quarter.
  • True Wealth Design's CorMedix position peaked at $40 in Q2 2026.
  • 6 funds tracked by Wall St. Rank held CorMedix as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.